Lucknow chosen to host fourth India International Science Festival

2018-01-23 16:11:25

The decision to hold the festival in Lucknow was taken at the first preparatory meeting for the 4th India International Science Festival chaired by Union Minister Dr. Harsh VardhanBy Team ABLEThe fourth edition of the India International Science Festival will be held in Lucknow. The exact dates and other details will be decided later. The decision to hold the festival in Lucknow was taken at the f

Read more

CSIR forges partnership with Japanese Universities and R&D Organizations

2018-01-23 16:09:54

The CSIR delegation to Japan held bilateral meetings with University of Tokyo and RIKEN Brain Science Institute to build R&D cooperation in areas of mutual interest, aimed at translational research.By Team ABLEThe Council of Scientific and Industrial Research (CSIR) has forged synergistic partnership with Japanese Universities and Research & Development (R&D) organizations to leverage

Read more

test\'s bold issue, question issue, color issue

2018-01-23 06:52:58

ththhth krtjjkjkrtjk this\'s my s\'troy

Read more

Panacea Biotec, Serum Institute of India ink two long-term agreements

2018-01-19 10:24:02

Under the collaboration, Serum Institute of India is entitled to manufacture and sell pertussis and Salk-based injectable polio vaccine-based hexavalent vaccine developed and commercialized by Panacea BiotecBy Team ABLEPopular biotechnology company, Panacea Biotec has signed two long term agreements with Serum Institute of India (SII) and SII\'s wholly owned subsidiary, Bilthovan Biologicals B. Un

Read more

Biocon collaborates with Sandoz on next-generation biosimilars

2018-01-19 09:55:45

This new partnership with Sandoz is a significant milestone in Biocon’s journey of developing advanced therapies that have the potential to benefit billions of patients.By Team ABLEAsia\'s premier biopharmaceuticals company Biocon Ltd and Sandoz, a Novartis division and a global leader in biosimilars, have announced a global partnership to develop, manufacture and commercialize multiple biosimil

Read more

BT cotton seeds effective: Monsanto reports to GoI

2018-01-19 09:54:28

US-based biotech major Monsanto\'s India JV firm MMBL has written to the government asserting that its BT technology seeds continues to be effective in controlling pest.By Team ABLEAt New Delhi, terming that industry body NSAI\'s threat to stop sale of BT cotton seeds as ‘irresponsible’, US-based biotech major Monsanto\'s India JV firm MMBL has written to the government asserting that its BT t

Read more

Minister of State for Health Anupriya Patel reviews the activities of National Centre for Disease Control

2018-01-19 09:53:00

Minister Anupriya Patel reviewed the activities of National Centre for Disease Control and has issued necessary directions for disease surveillanceBy Team ABLEMinister of State for Health and Family Welfare, Anupriya Patel has reviewed the activities of National Centre for Disease Control and has issued necessary directions for disease surveillance, monitoring of health status, educating the publi

Read more

Advanta Seeds opens new biotechnology center

2018-01-18 06:52:39

The center will accelerate Advanta Seeds’ research and development capabilities for the company’s key crops - sorghum, corn, vegetables sunflower, canola and rice.By Team ABLEAdvanta Seeds, a global agriculture company specializing in seeds and agricultural solutions, opens a new state-of-the-art biotechnology facility in College Station, Texas, USA.The new Biotechnology Center is a result of

Read more

2018-01-18 06:50:18

Marken has opened a new Kit Building Center in Shanghai, the company’s third location in addition to Hamburg and Singapore.By Team ABLEMarken has announced the opening of a new Kit Building Center in Shanghai, the company’s third location in addition to Hamburg and Singapore.The new 370 square meter facility is centrally located in the in the Pudong district and includes a processing area for

Read more

Vaccitech secures £20m to further Universal Flu Vaccine clinical trials

2018-01-18 06:47:53

Currently based at the Oxford Science Park, Vaccitech will use the funding to expand its business, develop its lab structure, and to push its influenza and other programsBy Team ABLEVaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20m ($27.1m) in Series A financing.The round was co-led by new investors GV, Sequo

Read more